<code id='E2D7CA3E97'></code><style id='E2D7CA3E97'></style>
    • <acronym id='E2D7CA3E97'></acronym>
      <center id='E2D7CA3E97'><center id='E2D7CA3E97'><tfoot id='E2D7CA3E97'></tfoot></center><abbr id='E2D7CA3E97'><dir id='E2D7CA3E97'><tfoot id='E2D7CA3E97'></tfoot><noframes id='E2D7CA3E97'>

    • <optgroup id='E2D7CA3E97'><strike id='E2D7CA3E97'><sup id='E2D7CA3E97'></sup></strike><code id='E2D7CA3E97'></code></optgroup>
        1. <b id='E2D7CA3E97'><label id='E2D7CA3E97'><select id='E2D7CA3E97'><dt id='E2D7CA3E97'><span id='E2D7CA3E97'></span></dt></select></label></b><u id='E2D7CA3E97'></u>
          <i id='E2D7CA3E97'><strike id='E2D7CA3E97'><tt id='E2D7CA3E97'><pre id='E2D7CA3E97'></pre></tt></strike></i>

          fashion

          fashion

          author:entertainment    Page View:6
          Mayo Clinic, in Rochester, Minnesota on
          Photo by KEREM YUCEL/AFP via Getty Images

          SAN FRANCISCO — Mayo Clinic has signed Silicon Valley tech startup Cerebras as its first generative AI partner, the health system announced Monday.

          The health system — known for its cutting-edge research and willingness to partner with tech companies — will give Cerebras millions of dollars to help build technology tools based on Mayo’s trove of de-identified patient data, leaders announced at the J.P. Morgan Healthcare Conference. Mayo and Cerebras did not disclose the dollar amount, but Cerebras said it was a multimillion, multi-year contract.

          advertisement

          With roughly 380 employees, Cerebras builds and sells supercomputers specifically designed for AI applications across several industries — pitting the upstart in direct competition with the market leader Nvidia Corp. Life sciences giants including GSK have used its technology for drug discovery, and it has partnered with a health network in United Arab Emirates, but this is Cerebras’ first AI contract with a U.S. health system. The deal gives Mayo access to Cerebras’ supercomputers as well as a Cerebras team to help develop health-tuned models; Mayo will then own whatever they build.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Alkermes shareholders re
          Alkermes shareholders re

          MarkLennihan/APAlkermesshareholdersvotedThursdaytore-electallofthedrugmaker’scurrentdirectors,ending

          read more
          FDA does about
          FDA does about

          JustinKlee,left,andJoshuaCohen,bothco-foundersandco-CEO'sofAmylyxPharmaceuticals.KayanaSzymczakforST

          read more
          United colonoscopy coverage change 'may cost lives,' doctors say
          United colonoscopy coverage change 'may cost lives,' doctors say

          AdobeWhengastroenterologistslearnedinMarchthatUnitedHealthcareplanstobarricademanycolonoscopiesbehin

          read more

          RSV vaccines may be linked to small increased risk of developing GBS

          CourtesyPfizerThenewvaccinesthatprotectolderadultsagainstrespiratorysyncytialvirus,orRSV,maybelinked